ASLAN Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

World News: . []

SINGAPORE Aug 06 2018 GLOBE NEWSWIRE -- ASLAN Pharmaceuticals NASDAQASLN TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe , today...

More news and information about ASLAN PHARMACEUTICALS LIMITED

Published By:

Globe Newswire: 09:05 GMT Monday 6th August 2018

Published: .

Search for other references to "aslan" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us